Analysis of T-cell immune response in renal cell carcinoma: Polarization to type 1-like differentiation pattern, clonal T-cell expansion and tumor-specific cytotoxicity

International Journal of Cancer

Volumn 72, Issue 3, 1997, Pages 431-440

  Angevin, Eric ^a,b   Kremer, Florence ^a   Gaudin, Catherine ^a   Hercend, Thierry ^a   Triebel, Frédéric ^a,b  

^a INSERM   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR;

ADULT; AGED; ARTICLE; CELL CLONE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MALE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY;

AGED; ANTIGENS, CD; CARCINOMA, RENAL CELL; CELL DIFFERENTIATION; CLONE CELLS; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HUMANS; KIDNEY NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0030741309     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970729)72:3<431::AID-IJC10>3.0.CO;2-F     Document Type: Article

References (21)

1. ALEXANDER, J.P., KUDOH, S., MELSOP, K.A., HAMILTON, T.A., EDINGER, M.G., TUBBS, R.R., SICA, D., TUASON, L., KLEIN, E., BUKOWSKI, R.M. and FINKE, J.H., T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. Cancer Res., 53, 1380-1387 (1993).
2. ALEXANDER, R.B., FITZGERALD, E.B., MIXON, A., CARTER, C.S., JAKOBSEN, M., COHEN, P.A. and ROSENBERG, S.A., Helper T cells infiltrating human renal cell carcinomas have the phenotype of activated memory-like T lymphocytes. J. Immunother., 17, 39-46 (1995).
3. ANGLARD, P., TRAHAN, E., LIU, S., LATIF, F., MERINO, M.J., LERMAN, M.I., ZBAR, B. and LINEMAN, W.M., Molecular and cellular characterization of human renal cell carcinoma cell lines. Cancer Res., 52, 348-356 (1992).
4. 4+ T cells are associated with IFN-gamma production. FASEB J., 10, 769-776 (1996).
5. BAIXERAS, E., HUARD, B., MIOSSEC, C., JITSUKAWA, S., MARTIN, M., HERCEND, T., AUFFRAY, C., TRIEBEL, F. and PIATIER-TONNEAU, D., Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens. J. exp. Med., 176, 327-337 (1992).
6. BERNHARD, H., KARBACH, J., WÖLFEL, T., BUSCH, P., STORKEL, S., STOCKLE, M., WÖLFEL, C., SELIGER, B., HUBER, C., MEYER ZUM BUSCHENFELDE, K.H. and KNUTH, A., Cellular immune response to human renal-cell carcinomas: definition of a common antisen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones. Int. J. Cancer, 59, 837-842 (1994).
7. BLAY, J.Y., NEGRIER, S., COMBARET, V., ATTALL S., GOILLOT, E., MERROUCHE, Y., RAVAULT, A.M.A., TOURANI, J.M., MOSKOVTCHENKO, J.F., PHILIP, T. and FAVROT, M., Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma. Cancer Res., 52, 3317-3322 (1992).
8. BROUWENSTIJN, N., GAUGLER, B., KRUSE, K.M., VAN DER SPEK, C.W., MULDER, A., OSANTO, S., VAN DEN EYNDE, B.J. and SCHRIER, P.I., Renal-cell carcinoma-specific lysis by cytotoxic T-lymphocyte clones isolated from peripheral blood lymphocytes and tumor-infiltrating lymphocytes. Int. J. Cancer, 68, 177-182 (1996).
9. CAIGNARD, A., GUILLARD, M., GAUDIN, C., ESCUDIER, B., TRIEBEL, F. and DIETRICH, P.-Y., In situ demonstration of renal-cell-carcinoma-specific T-cell clones. Int. J. Cancer, 66, 564-570 (1996).
10. EBERT, T., BANDER, N.H., FINSTAD, C.L., RAMSAWAK, R.D. and OLD, L.J., Establishment and characterization of human renal cancer and normal kidney cell lines. Cancer Res., 50, 5531-5536 (1990).
11. GAUDIN, C., DIETRICH, P.Y., ROBACHE, S., GUILLARD, M., ESCUDIER, B., TERRIER-LACOMBE, M.J., KUMAR, A., TRIEBEL, F. and CAIGNARD, A., In vivo local expansion of clonal T cell subpopulations in renal cell carcinoma. Cancer Res., 55, 685-690 (1995).
12. HUARD, B., GAULARD, P., FAURE, F., HERCEND, T. and TRIEBEL, F., Cellular expression and tissue distribution of the human LAG-3-encoded protein, a MHC class II ligand. Immunogenetics, 39, 213-217 (1994).
13. 4+ T cell clone response following LAG-3 binding. Europ. J. Immunol., 26, 1180-1186 (1996).
14. MACKENSEN, A., FERRADINI, L., CARCELAIN, G., TRIEBEL, F., FAURE, F., VIEL, S. and HERCEND, T., Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanoma. Cancer Res., 53, 3569-3573 (1993).
15. MAEURER, M.J., MARTIN, D.M., CASTELLI, C., ELDER, E., LEDER, G., STORKUS, W.J. and LOTZE, M.T., Host immune response in renal cell cancer, interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected turnor-infiltrating lymphocytes. Cancer Immunol. Immunother., 41, 111-121 (1995).
16. PUISIEUX, I., BAIN, C., MERROUCHE, Y., MALACHER, P., KOURILSKY, P., EVEN, J. and FAVROT, M., Restriction of the T-cell repertoire in tumor-infiltrating lymphocytes from nine patients with renal-cell carcinoma relevance of the CDR3 length analysis for the identification of in situ clonal T-cell expansions. Int. J. Cancer, 66, 201-208 (1996).
17. SCHENDEL, D.J., GANSBACHER, B., OBERNEDER, R., KRIEGMAIR, M., HOFSTETTER, A., RIETHMULLER, G. and SEGURADO, O.G., Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines. J. Immunol., 151, 4209-4220 (1993).
18. TAKENAWA, J., KANEKO, Y., FUKUMOTO, M., FUKATSU, A., HIRANO, T., FUKUYAMA, H., NAKAYAMA, H., FUJITA, J. and YOSHIDA, O., Enhanced expression of interleukin-6 in primary human renal cell carcinomas. J. nat. Cancer Inst., 83, 1668-1672 (1991).
19. TARTOUR, E., LATOUR, S., MATHIOT, C., THIOUNN, N., MOSSERI, V., JOYEUX, I., D'ENGHIEN, C.D., LEE, R., DEBRÉ, B. and FRIDMAN, W.H., Variable expression of CD3-ζ chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: relationship with TIL phenotype and function. Int. J. Cancer, 63, 205-212 (1995).
20. WANG, Q., REDOVAN, C., TUBBS, R., OLENCKI, T., KLEIN, E., KUDOH, S., FINKE, J. and BUKOWSKI, R.M., Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytes. Int. J. Cancer, 61, 780-785 (1995).
21. WHITESIDE, T.L. and PARMIANI, G., Tumor-infiltrating lymphocytes: their phenotype, functions and clinical use. Cancer Immunol. Immunother., 39, 15-21 (1994).